OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is aiming to capitalize on the growing social acceptance of cannabinoid medical products through its wholly-owned Israeli subsidiary World Cannabis Ltd. OWC plans to discover, develop and commercialize cannabis therapeutics to address critical medical conditions. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is also developing a cannabis soluble tablet and topical cream.
Cannabis has a history that stretches back over 10,000 years in Asia. The earliest uses were for food and clothing. The Chinese first discovered the medicinal effects of cannabis and used it, mixed with wine, as an anesthetic. Other uses, such as for hair loss or constipation, were also treated with the plant but no determination of its efficacy is recorded. What we do know is that cannabis has such a strong presence in traditional Chinese medicine that one book named it as one of the 50 fundamental herbs in Chinese medicine.
As a result of its frequent use and reputation, medicinal practitioners all over the world adopted the use of cannabis through the ages. It was a key treatment for healthcare practitioners in Ancient Egypt, Greece, and Rome. Its use has been documented during the Middle Ages. But cannabinoid medical products hit the mainstream in Jamaica when Dr. Lockhart and Manley West noticed that Jamaicans had an unusually low rate of glaucoma in their population. After some scientific research, they received permission to market the drug Canasol. More recently many U.S. states have approved the use of medical marijuana and cannabinoid products.
Enter OWC Pharmaceutical Research Corp (OTCMKTS:OWCP). OWC is currently working to develop formulations utilizing cannabinoids. So far the company has entered into a collaboration agreement with a major Israeli medical center. The collaboration includes initiating pre-clinical and clinical studies to determine the effectiveness of cannabidiol and tetrahydrocannabinol, or combinations of the two, to treat multiple myeloma, psoriasis, and fibromyalgia. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has filed eight patents to protect and support their efforts.
How seriously are their efforts being taken? Just recently the company announced their invitation to present at the Spring Edition of the Monaco Growth Forum. Dr. Baruch will present OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) approach to the forum and he will also serve as the keynote speaker at a cocktail reception for the forum participants.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is very liquid – the average daily volume is over three million shares.
I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.
About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.